An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease.
Open Access
- 13 November 2000
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 160 (20) , 3123-3127
- https://doi.org/10.1001/archinte.160.20.3123
Abstract
In the primary prevention of cardiovascular disease, in contrast to the recommendations of the American College of Chest Physicians and the American Heart Association, the US Food and Drug Administration recently stated that there was insufficient evidence to judge whether aspirin therapy decreases the risk of a first myocardial infarction.This publication has 1 reference indexed in Scilit:
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989